Bruce Japsen

A Chicago area pharmaceutical industry entrepreneur has launched a new company in hopes of capturing a piece of the growing market to develop combination medications that treat multiple ailments with...

The "atmosphere" may finally be right for Abbott Laboratories to finally sell its 50 percent stake in a Lake Forest drugmaker, says Abbott Chief Executive Miles White. With Abbott shedding...

Adding more credibility to its research into alternative methods for oncologic medical care, Cancer Treatment Centers of America said it has won federal approval to begin a clinical trial studying...

A Democratic takeover of Congress could temper the benefit that drugmakers and health insurance companies have reaped from the new Medicare part D prescription benefit, which brought them millions of...

The regulatory environment for U.S. businesses could change significantly next year if Democrats gain control of one or both houses of Congress in Tuesday's elections, as some polls predict. Since...

Abbott Laboratories' experimental dissolvable heart stent is safe and working for patients in an early human clinical trial, the company said Tuesday. The North Chicago-based medical products giant hopes the...

In an aggressive move to win over consumers that also threatens to shake up the $250 billion pharmaceutical business, Wal-Mart Stores Inc. said Thursday that it plans to test the...

In the diagnostics industry's version of David vs. Goliath, a federal jury awarded a tiny Belgian biotechnology company $7 million in damages after determining that Abbott Laboratories infringed on one...

Moving away from the traditional hospital ad campaign that often touts quality, smiling doctors or a market research firm's ranking of some variety, Edward Hospital in Naperville is offering consumers...